TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells.
about
Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel diseaseSerum adipokines in inflammatory bowel disease.Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic MiceThe Effect of Traditional Chinese Formula Danchaiheji on the Differentiation of Regulatory Dendritic Cells.Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation.Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.Generation of regulatory dendritic cells after treatment with paeoniflorin.CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production
P2860
Q27006589-FB2CB75B-A558-412F-89B1-B06EBD42F3D0Q33735303-DF24B197-A91D-45F8-BAC1-BB885D074734Q33772861-3A1C8193-00CF-4EB3-9B0D-D9F748EEC458Q34222959-2A534175-DF82-4A08-886D-96EF0BE38554Q36462926-EDCB4364-D810-48CA-917C-64B1FE2727B7Q37156931-36F2565A-EB77-49F8-A734-5F16E47D8038Q37358329-0DC495BD-087C-4A50-A260-86DECE672C33Q37774322-9BD666C4-AE07-41B3-8E02-8D4D348A11ABQ38881545-7EC519DD-E35C-4C1F-91FD-D86C7D7C1DFBQ44516536-B8666BE0-47B3-4566-9446-60D20075D292Q47348999-E4B88C18-83C5-431C-95A3-4B2AA9A078EAQ56889158-50D6FE80-0C33-438E-BBD5-46039C56AF68
P2860
TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@en
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@nl
type
label
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@en
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@nl
prefLabel
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@en
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@nl
P2093
P2860
P356
P1476
TGF-beta1 gene-modified, immat ...... +)Foxp3(+) regulatory T cells.
@en
P2093
Jianli Wang
Xuetao Cao
Zhijian Cai
P2860
P2888
P356
10.1038/CMI.2009.107
P577
2010-01-01T00:00:00Z
P6179
1042779811